全文获取类型
收费全文 | 16186篇 |
免费 | 1359篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 63篇 |
儿科学 | 571篇 |
妇产科学 | 513篇 |
基础医学 | 2337篇 |
口腔科学 | 310篇 |
临床医学 | 1123篇 |
内科学 | 3948篇 |
皮肤病学 | 200篇 |
神经病学 | 1688篇 |
特种医学 | 395篇 |
外科学 | 1274篇 |
综合类 | 111篇 |
一般理论 | 3篇 |
预防医学 | 2800篇 |
眼科学 | 153篇 |
药学 | 921篇 |
中国医学 | 66篇 |
肿瘤学 | 1086篇 |
出版年
2023年 | 394篇 |
2022年 | 670篇 |
2021年 | 655篇 |
2020年 | 636篇 |
2019年 | 441篇 |
2018年 | 495篇 |
2017年 | 581篇 |
2016年 | 553篇 |
2015年 | 664篇 |
2014年 | 1019篇 |
2013年 | 907篇 |
2012年 | 567篇 |
2011年 | 535篇 |
2010年 | 730篇 |
2009年 | 679篇 |
2008年 | 421篇 |
2007年 | 477篇 |
2006年 | 375篇 |
2005年 | 355篇 |
2004年 | 327篇 |
2003年 | 318篇 |
2002年 | 378篇 |
2001年 | 345篇 |
2000年 | 296篇 |
1999年 | 311篇 |
1998年 | 148篇 |
1997年 | 150篇 |
1996年 | 158篇 |
1995年 | 134篇 |
1994年 | 133篇 |
1993年 | 112篇 |
1992年 | 260篇 |
1991年 | 245篇 |
1990年 | 264篇 |
1989年 | 214篇 |
1988年 | 233篇 |
1987年 | 160篇 |
1986年 | 82篇 |
1985年 | 98篇 |
1984年 | 115篇 |
1983年 | 107篇 |
1982年 | 108篇 |
1981年 | 120篇 |
1980年 | 98篇 |
1979年 | 88篇 |
1978年 | 89篇 |
1977年 | 93篇 |
1974年 | 94篇 |
1973年 | 86篇 |
1972年 | 83篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
Raymond J. Chan RN PhD Vivienne E. Milch MBBS MHPol Fiona Crawford-Williams PhD Oluwaseyifunmi Andi Agbejule BRadTherapy Ria Joseph MNutrDiet Jolyn Johal BND Narayanee Dick BSc Matthew P. Wallen PhD Julie Ratcliffe PhD Anupriya Agarwal MBBS Larissa Nekhlyudov MD Matthew Tieu PhD Manaf Al-Momani BPharm Scott Turnbull PhD Rahul Sathiaraj MPH Dorothy Keefe MBBS MD Nicolas H. Hart PhD 《CA: a cancer journal for clinicians》2023,73(6):565-589
Patient navigation is a strategy for overcoming barriers to reduce disparities and to improve access and outcomes. The aim of this umbrella review was to identify, critically appraise, synthesize, and present the best available evidence to inform policy and planning regarding patient navigation across the cancer continuum. Systematic reviews examining navigation in cancer care were identified in the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Embase, Cumulative Index of Nursing and Allied Health (CINAHL), Epistemonikos, and Prospective Register of Systematic Reviews (PROSPERO) databases and in the gray literature from January 1, 2012, to April 19, 2022. Data were screened, extracted, and appraised independently by two authors. The JBI Critical Appraisal Checklist for Systematic Review and Research Syntheses was used for quality appraisal. Emerging literature up to May 25, 2022, was also explored to capture primary research published beyond the coverage of included systematic reviews. Of the 2062 unique records identified, 61 systematic reviews were included. Fifty-four reviews were quantitative or mixed-methods reviews, reporting on the effectiveness of cancer patient navigation, including 12 reviews reporting costs or cost-effectiveness outcomes. Seven qualitative reviews explored navigation needs, barriers, and experiences. In addition, 53 primary studies published since 2021 were included. Patient navigation is effective in improving participation in cancer screening and reducing the time from screening to diagnosis and from diagnosis to treatment initiation. Emerging evidence suggests that patient navigation improves quality of life and patient satisfaction with care in the survivorship phase and reduces hospital readmission in the active treatment and survivorship care phases. Palliative care data were extremely limited. Economic evaluations from the United States suggest the potential cost-effectiveness of navigation in screening programs. 相似文献
4.
《Revue d'épidémiologie et de santé publique》2022,70(5):230-242
BackgroundThis systematic review aims to determine the epidemiological profile, etiology and risk factors, prevention, diagnosis, treatment, cost-effectiveness, survival, and quality of life related to cervical cancer in Morocco.MethodsThis study was conducted according to the recommendations of the "preferred reporting items for systematic reviews and meta-analysis." The PubMed, ScienceDirect, Springer, Web of Science data bases were used, as was Google Scholar for the grey literature. The review protocol was registered in the PROSPERO register (CRD42021235241).ResultsFifty studies were selected. The mean age was 49.31 ±6.3 years. HPV infection prevalence ranged from 13.30% to 76%, with a peak in HIV-positive women. Acceptability of the HPV vaccine was higher among parents (35% and 82%) than among adolescents (16.9% to 46.6%). Knowledge of the vaccine and its price are two key factors related to vaccine acceptability among parents. This systematic review highlights that the fact that few eligible women (not more than 11%) were participating in the cervical cancer screening program. Moroccan women's level of knowledge and awareness regarding cervical cancer screening was low, negatively impacting their use of such screening tools, as illustrated by the high percentage (mean 76.32% ± 17.21) of women who had never been screened for cervical cancer. Treatment was the most significant component of the global care budget (95.87%), with an annual cost of $13,027,609. Five-year overall survival ranged from 41.3% to 73.6%, with higher survival rates for patients diagnosed at an earlier stage (77.3–85% for stage I). Lastly, low quality of life was observed in women with tumors at an advanced stage who had received brachytherapy and lacked social support.ConclusionsSubjects that require further investigation include Moroccan women's knowledge, attitudes, and awareness, especially among those at high risk of developing cervical cancer, and its impact on their quality of life and survival. 相似文献
5.
6.
《Clinical therapeutics》2022,44(2):193-214.e1
PurposeThe goal of this study was to review the role of human milk in shaping the infant intestinal microbiota and the potential of human milk bioactive molecules to reverse trends of increasing intestinal dysbiosis and dysbiosis-associated diseases.MethodsThis narrative review was based on recent and historic literature.FindingsHuman milk immunoglobulins, oligosaccharides, lactoferrin, lysozyme, milk fat globule membranes, and bile salt–stimulating lipase are complex multifunctional bioactive molecules that, among other important functions, shape the composition of the infant intestinal microbiota.ImplicationsThe co-evolution of human milk components and human milk–consuming commensal anaerobes many thousands of years ago resulted in a stable low-diversity infant microbiota. Over the past century, the introduction of antibiotics and modern hygiene practices plus changes in the care of newborns have led to significant alterations in the intestinal microbiota, with associated increases in risk of dysbiosis-associated disease. A better understanding of mechanisms by which human milk shapes the intestinal microbiota of the infant during a vulnerable period of development of the immune system is needed to alter the current trajectory and decrease intestinal dysbiosis and associated diseases. 相似文献
7.
8.
9.
10.